- Home
- HCM vs ERO Comparison
HCM vs ERO Comparison
Compare HCM & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCM | ERO |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | Hong Kong | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HCM | ERO |
|---|---|---|
| Price | $14.38 | $36.83 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $13.75 | ★ $32.50 |
| AVG Volume (30 Days) | 52.8K | ★ 2.2M |
| Earning Date | 03-18-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 696.31 |
| EPS | 0.53 | ★ 1.33 |
| Revenue | ★ $602,197,000.00 | $588,229,000.00 |
| Revenue This Year | N/A | $67.70 |
| Revenue Next Year | $15.54 | $45.19 |
| P/E Ratio | ★ $5.43 | $25.69 |
| Revenue Growth | N/A | ★ 26.74 |
| 52 Week Low | $11.51 | $9.30 |
| 52 Week High | $19.50 | $39.80 |
Technical Indicators
Market Signals| Indicator | HCM | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 66.43 |
| Support Level | $14.16 | $32.62 |
| Resistance Level | $15.82 | $39.80 |
| Average True Range (ATR) | 0.39 | 1.92 |
| MACD | -0.13 | 0.23 |
| Stochastic Oscillator | 10.14 | 71.65 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.